Skip to main content
TipRanks
Go Ultimate75% OFF

Cue Biopharma (CUE) Q4 2023 Earnings Report

671 Followers

CUE Q4 2023 EPS Results

Actual EPS
-$7.50
Consensus EPS
-$8.46
Beat/Miss
Beat by +$0.96
One Year Ago EPS
-$8.70

CUE Q4 2023 Revenue Results

Actual Revenue
$1.72M
Expected Revenue
$1.21M
Beat/Miss
Beat by +$506.00K
YoY Revenue Growth
+1035.38%

Earnings Announcement Details

Quarter
Q4 2023
Date
04/08/2024
Time
After Close
Conference Call
Monday, April 8, 2024
CUE Upcoming Earnings

Cue Biopharma's next earnings date is estimated for March 23, 2027, based on past reporting schedules.

Q4 2023 Earnings Call Audio

CUE Q4 2023 Earnings Call
0:00 / 0:00

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

CUE Earnings History

CUE earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 23, 20272026 (Q4)-1.67-0.3――
Nov 16, 20262026 (Q3)-2.24-4.74-2.1-125.71% (-2.64)
Aug 17, 20262026 (Q2)-1.69-24.14-2.7-794.07% (-21.44)
May 14, 20262026 (Q1)―-1.08-5.178.82% (+4.02)
Mar 16, 20262025 (Q4)-2.700.30-3.9107.69% (+4.20)
Nov 12, 20252025 (Q3)-2.80-2.10-5.158.82% (+3.00)
Aug 12, 20252025 (Q2)-3.90-2.70-655.00% (+3.30)
May 12, 20252025 (Q1)―-0.17-7.597.73% (+7.33)
Mar 31, 20252024 (Q4)-4.60-5.10-7.532.00% (+2.40)
Nov 14, 20242024 (Q3)-5.47-5.10-7.229.17% (+2.10)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed